menu
    • menu

    Company profile for Serb

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    SERB is a European specialty pharmaceutical group focused on prescription medicines which address rare and life-threatening diseases. Following strategic acquisitions and targeted developments, SERB has succeeded in establishing a consistent drugs portfolio focused on niche specialty pharmaceuticals to ensure continuous availability of life-saving medicines and answer unmet medical needs. Our commitment is to continue to off...
    SERB is a European specialty pharmaceutical group focused on prescription medicines which address rare and life-threatening diseases. Following strategic acquisitions and targeted developments, SERB has succeeded in establishing a consistent drugs portfolio focused on niche specialty pharmaceuticals to ensure continuous availability of life-saving medicines and answer unmet medical needs. Our commitment is to continue to offer essential drugs meeting Public Health needs.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    SerbBelgium Flag
    Country
    Country
    Belgium
    Address
    Address
    Avenue Louise 480 Ixelles Brussels, 1050
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://serb.eu/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    SERB Pharmaceuticals Agrees to Acquire Y-mAbs Therapeutics
    SERB Pharmaceuticals Agrees to Acquire Y-mAbs Therapeutics

    05 Aug 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/08/05/3127378/0/en/SERB-Pharmaceuticals-Agrees-to-Acquire-Y-mAbs-Therapeutics.html

    GLOBENEWSWIRE
    05 Aug 2025
    Share Share
    Serb's Amversio (Betaine Anhydrous) Receives Approval in Europe
    Serb's Amversio (Betaine Anhydrous) Receives Approval in Europe

    08 Jun 2023

    // EMA

    https://www.ema.europa.eu/en/documents/overview/amversio-epar-medicine-overview_en.pdf

    EMA
    08 Jun 2023
    Share Share
    Soligenix Announces Strategic Partnership with SERB Pharmaceuticals
    Soligenix Announces Strategic Partnership with SERB Pharmaceuticals

    25 Jul 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/soligenix-announces-strategic-partnership-with-serb-pharmaceuticals-to-supply-its-novel-ricin-antigen-301591564.html

    PRNEWSWIRE
    25 Jul 2022
    Share Share
    Serb SA's Amifampridine Serb (amifampridine) Receives Approval in Europe
    Serb SA's Amifampridine Serb (amifampridine) Receives Approval in Europe

    25 May 2022

    // EMA

    https://www.ema.europa.eu/en/documents/overview/amifampridine-serb-epar-medicine-overview_en.pdf

    EMA
    25 May 2022
    Share Share
    SERB SAS' Voraxaze (glucarpidase) Receives Approval in Europe
    SERB SAS' Voraxaze (glucarpidase) Receives Approval in Europe

    20 Jan 2022

    // EMA

    https://www.ema.europa.eu/en/medicines/human/EPAR/voraxaze-0

    EMA
    20 Jan 2022
    Share Share
    SERB receives positive CHMP opinion for Voraxaze® (glucarpidase) as Rescue Therapy for High Dose Methotrexate Toxicity
    SERB receives positive CHMP opinion for Voraxaze® (glucarpidase) as Rescue Therapy for High Dose Methotrexate Toxicity

    25 Nov 2021

    // PRESS RELEASE

    https://www.pharmacompass.com/pdf/news/serb-receives-positive-chmp-opinion-for-voraxaze-glucarpidase-as-rescue-therapy-for-high-dose-methotrexate-toxicity-1639817595.pdf

    PRESS RELEASE
    25 Nov 2021
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search